Haem: Acute Leukaemia Flashcards

1
Q

Which cell level does CML tend to occur in?

A

Pluripotent haematopoietic stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which cell level does AML tend to occur in?

A

Pluripotent haematopoietic stem cell or multipotent myeloid stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some types of chromosomal abnormalities that are associated with AML.

A
  • Duplications
  • Loss
  • Translocation
  • Inversion
  • Deletion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can altered DNA sequence lead to leukaemia?

A
  • By the creation of a fusion gene
  • By abnormal regulation of genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which chromosomal duplications are most commonly associated with AML?

A

8 and 21 (there is a predisposition seen in Down syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some molecular abnormalities that an occur in apparently normal chromosomes.

A
  • Point mutations
  • Loss of function of tumour suppressor genes
  • Partial duplication
  • Cryptic deletion (formation of a fusion gene by deletion of a small section of DNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some risk factors for AML.

A
  • Familial
  • Constitutional (e.g. Down syndrome)
  • Anti-cancer drugs
  • Irradiation
  • Smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are type 1 and type 2 abnormalities with regards to leukaemogenesis?

A
  • Type 1: promote proliferation and survival (anti-apoptosis)
  • Type 2: block differentation

NOTE: leukaemogenesis in AML requires multiple genetic hits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main role of transcription factors?

A
  • They bind to DNA, alter the structure to favour transcription and, ultimately, regulate gene expression
  • Disruption of transcription factors can result in failure of differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of how disruption of a transcription factor can lead to leukaemogenesis.

A
  • Core binding factor (CBF) is the master controller of haemopoiesis
  • Translocation 8;21 fuses RUNX1 leading to the formation of a fusion gene that drives leukaemia
  • The fusion transcription factor binds to co-repressors leading to a differentiation block
  • Inversion of chromosome 16 also affects CBF in a similar way
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which chromosomal aberration causes APML?

(Acute Promyelocytic leukaemia)

A

Translocation 15;17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a characteristic feature of APML? Why does this occur?

A
  • Haemorrhage - this is because APML is associated with DIC and hyperactive fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the fusion gene that is responsible for APML.

A

PML-RARA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In what way are the promyelocytes in APML considered ‘abnormal’?

A

They contain multiple Auer rods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how the variant version of APML is different from the original version.

A
  • The variant form has granules that are below the resolution of a light microscope
  • They also tend to have bilobed nuclei
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give a type 1 and type 2 mutation for APML.

A
  • Type 1: FLT3-ITD
  • Type 2: PML-RARA
17
Q

Give a type 1 and type 2 mutation for CBF leukaemias.

A
  • Type 1: sometimes mutated KIT
  • Type 2: mutations affecting function of CBF
18
Q

Which microscopic feature is pathognomonic of myeloid leukemias?

A

Auer rods

19
Q

Which stain can be used to distinguish myeloid leukaemias from other leukaemias?

A

Myeloperoxidase

20
Q

Name other similar stains that are not used as frequently for myeloid leukaemias (other than myeloperoxidase).

A
  • Sudan black
  • Non-specific esterase
21
Q

List the clinical features of AML.

A
  • Bone marrow failure (anaemia, neutropaenia, thrombocytopaenia)
  • Local infiltration (splenomegaly, hepatomegaly, gum infiltration, lymphadenopathy, CNS, skin)
  • Hyperviscosity if WBC is very high (can cause retinal haemorrhages and exudates)
22
Q

Outline the tests that may be used to diagnose AML.

A
  • Blood film
  • Bone marrow aspirate
  • Cytogenetic studies (done in EVERY patient)
  • Molecular studies and FISH
23
Q

What is aleukaemia leukaemia?

A

When there are no leukaemic cells in the peripheral blood but the bone marrow has been replaced

24
Q

Outline the supportive care given for AML.

A
  • Red cells
  • Platelets
  • FFC/cryoprecipitate in DIC
  • Antibiotics
  • Allopurinol (prevent gout)
  • Fluid and electrolyte balance
  • Chemotherapy
25
Q

What are the principles of treatment of AML?

A
  • Damage the DNA of leukaemic cells
  • Leave the normal cells unaffected
  • Combination chemotherapy is ALWAYS used
  • Usually given as 4-5 courses (2x remission induction + 2/3x consolidation)
  • Treatment usually lasts around 6 months
26
Q

List some determinants of prognosis in AML.

A
  • Patient characteristics
  • Morphology
  • Immunophenotyping
  • Cytogenetics
  • Response to treatment
27
Q

How to tell the difference between ALL and AML (without presence of granules or auer rods)

A

Immunophenotyping - Flow cytometry looking at known protein marker

28
Q

Outline the clinical features of ALL.

A
  • Bone marrow failure
  • Local infiltration
29
Q

What is a key difference in the origin of B-lineage and T-lineage ALL?

A
  • B-lineage starts in the bone marrow
  • T-lineage can start in the thymus (which may be enlarged)
30
Q

List some possible leukaemogenic mechanisms in ALL.

A

Protooncogene dysregulation due to chromosomal abnormalities (resulting in fusion genes, altered gene promoters)

31
Q

List some investigations used in the diagnosis of ALL.

A
  • FBC and blood film
  • Bone marrow aspirate
  • Immunophenotyping
  • Cytogenetic/molecular analysis
32
Q

What are the four phases of chemotherapy for ALL?

A
  • Remission induction
  • Consolidation and CNS therapy
  • Intensification
  • Maintenance
33
Q

How long does chemotherapy for ALL usually take? Why is it longer in boys?

A

2-3 years

Longer in boys because the testes are a site of accumulation of lymphoblasts

34
Q

Who receives CNS-directed chemotherapy? How can this be given?

A
  • All patients should receive CNS-directed chemotherapy
  • This can be given intrathecally or a high dose of chemotherapy could be given such that it penetrates the BBB
35
Q

Outline the supportive care for ALL.

A
  • Blood products
  • Antibiotics
  • General medical care (central line, gout management, hyperkalaemia management, sometimes dialysis)
36
Q

Cytochemistry stains for ALL vs AML

A

Myeloperoxidase, Sudan Black, Non-specific esterase

+ ive in AML

-ive in ALL